Tagged With CAR-T

Dispensed: How health insurance startups fared at the start of 2019, Impossible Foods' big burger change, and a look at uBiome's board


A cutting-edge new cancer treatment has two different price tags, and it could be the future of how we pay for drugs


A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to treat more patients



A CEO who sold his last cancer drug company for $12 billion just got $300 million to do it again


The hottest thing in cancer drug development just won a $9 billion endorsement


Celgene is buying the cancer-drug maker Juno Therapeutics for $9 billion



The hottest thing in cancer drug development is a takeover target again -- here's what you need to know about it


Celgene is reportedly in talks to buy a $5.5 billion cancer drugmaker


A new approach to treating blood cancer just got a promising set of results


A revolutionary treatment could help more than 10,000 people living with largely untreatable cancer


A cancer treatment that's part of 'a big new field of medicine' just got approved


A medical breakthrough that hacks genes to fight cancer just got approved, and it's the beginning of 'a big new field of medicine'



A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved


Here's why Gilead Sciences broke its dealmaking hiatus and splurged $12 billion on a cancer treatment


Gilead just handed a revolutionary kind of cancer treatment a $12 billon endorsement


A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got closer to approval



There's a race to get 2 revolutionary new cancer treatments on the market -- here's who's in the lead